Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
13-valent
18%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
18%
Anaplastic Thyroid Cancer
24%
Bile Duct Stricture
18%
Bile Leak
21%
CHEK2
44%
Chk2
18%
Cholangioscopy
18%
Cleft Palate
18%
Colon Adenocarcinoma
18%
Colorectal Cancer Screening
18%
Conjugate Vaccine
18%
Cost-utility Analysis
18%
Cyclin-dependent Kinase 4/6 Inhibitors
18%
D Cyclins
18%
DNA Damage Response Pathway
37%
DNA Repair Enzymes
18%
DNA Repair Genes
27%
EIF1AX
34%
Endoscopic Management
37%
Endotherapy
32%
Familial Non-medullary Thyroid Cancer
100%
FOXE1
18%
Gene Alteration
18%
Gene Content
18%
Germ Cells
24%
Germline Variants
21%
Invasive Pneumococcal Disease
18%
Low Rectal Cancer
18%
Lower Airways
18%
Malignant Struma Ovarii
18%
Pathogenic Variants
22%
Peak Nasal Inspiratory Flow
18%
Plastic Stent
26%
Portugal
56%
Post-cholecystectomy
37%
Predictive Value
18%
Predisposing Genes
37%
Proband
23%
Serotype Distribution
18%
SPRY4
18%
Stage IA2
18%
Stage IIA Colon Cancer
18%
Superantigen Genes
18%
Susceptibility Genes
25%
TERT Promoter mutation
18%
Thyroid Cancer
77%
Thyroid Cancer Cell Lines
18%
Tumor
19%
Tumourigenesis
18%
Biochemistry, Genetics and Molecular Biology
Amyloid Protein
6%
Bioinformatics
12%
BRCA2
6%
BUB1B
6%
Cancer Cell
6%
Cancer Genetics
6%
Carcinogenesis
18%
Cell Dedifferentiation
12%
CHEK2
44%
Conformational Change
6%
Dideoxynucleotide Sequencing
8%
DNA Repair
48%
DNA Repair Protein
6%
ERCC2
6%
Exome Sequencing
18%
extracellular signal regulated kinase
31%
Extracellular Signal-Regulated Kinases
6%
FANCA
6%
FANCD2
6%
FANCF
6%
Founder Effect
18%
FOXE1
18%
Gene Expression
6%
Gene Mutation
25%
Genetic Divergence
18%
Genetics
25%
Germ Cell
55%
Germline
55%
Germline Mutation
14%
Haplotype
9%
In Silico Study
6%
Kinase
12%
Leukocyte
9%
MEK Inhibitor
6%
Messenger RNA
6%
Missense
12%
Next Generation Sequencing
21%
PALB2
6%
Phosphotransferase
12%
Proband
23%
Promoter Region
24%
Protein Kinase Domain
6%
Protein Structure
18%
PTCH1
6%
Rare Variant
6%
Teratoma
18%
Tertiary Structure
6%
Tumor Progression
9%
Tumor-Related Gene
6%
Wild Type
14%
Medicine and Dentistry
Adverse Event
6%
Airway Flow
18%
Allergic Asthma
9%
Allergic Rhinitis
9%
Anal Sphincterotomy
18%
Anaplastic Thyroid Carcinoma
18%
Bile
9%
Biliary Tract Endoscopy
18%
Cancer Therapy
18%
Carcinogenesis
18%
Cell Dedifferentiation
12%
Cholestasis
18%
Cohort Analysis
21%
Colon Adenocarcinoma
18%
Colon Carcinoma
9%
Conjugate Vaccine
18%
Differentiated Thyroid Cancer
6%
Endoscopic Stenting
5%
Gene Mutation
6%
Germ Cell
22%
Hyperplasia
14%
Minoxidil
7%
Peak Expiratory Flow
7%
Peak Nasal Inspiratory Flow
18%
Pneumococcal Infection
18%
Prognostic Factor
14%
Promoter Region
18%
Prospective Study
18%
Protein Structure
18%
Rectum Cancer
18%
Recurrent Disease
48%
Rescue Therapy
6%
Retrospective Study
6%
School-Aged Child
18%
Self-Expandable Metallic Stent
12%
Serotype
18%
Somatics
18%
Stricture
13%
Thyroid Cancer
37%
Thyroid Carcinoma
18%
Thyroid Tumor
14%
Tumor
18%
Tumor-Related Gene
6%